| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |